265 related articles for article (PubMed ID: 14999811)
21. Doublecortin immunoreactivity in giant cells of tuberous sclerosis and focal cortical dysplasia.
Mizuguchi M; Yamanouchi H; Becker LE; Itoh M; Takashima S
Acta Neuropathol; 2002 Oct; 104(4):418-24. PubMed ID: 12200630
[TBL] [Abstract][Full Text] [Related]
22. Abnormal giant cells in the cerebral lesions of tuberous sclerosis complex.
Mizuguchi M
Congenit Anom (Kyoto); 2007 Mar; 47(1):2-8. PubMed ID: 17300684
[TBL] [Abstract][Full Text] [Related]
23. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures.
van Scheppingen J; Iyer AM; Prabowo AS; Mühlebner A; Anink JJ; Scholl T; Feucht M; Jansen FE; Spliet WG; Krsek P; Zamecnik J; Buccoliero AM; Giordano F; Genitori L; Kotulska K; Jozwiak S; Jaworski J; Liszewska E; van Vliet EA; Aronica E
Glia; 2016 Jun; 64(6):1066-82. PubMed ID: 27014996
[TBL] [Abstract][Full Text] [Related]
24. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
25. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
26. Stochastic model of Tsc1 lesions in mouse brain.
Prabhakar S; Goto J; Zhang X; Sena-Esteves M; Bronson R; Brockmann J; Gianni D; Wojtkiewicz GR; Chen JW; Stemmer-Rachamimov A; Kwiatkowski DJ; Breakefield XO
PLoS One; 2013; 8(5):e64224. PubMed ID: 23696872
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
[TBL] [Abstract][Full Text] [Related]
28. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
[TBL] [Abstract][Full Text] [Related]
29. Patterns of expression of TSC-22 protein in astrocytic gliomas.
Shostak KO; Dmitrenko VV; Vudmaska MI; Naidenov VG; Beletskii AV; Malisheva TA; Semenova VM; Zozulya YP; Demotes-Mainard J; Kavsan VM
Exp Oncol; 2005 Dec; 27(4):314-8. PubMed ID: 16404353
[TBL] [Abstract][Full Text] [Related]
30. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers.
Talos DM; Kwiatkowski DJ; Cordero K; Black PM; Jensen FE
Ann Neurol; 2008 Apr; 63(4):454-65. PubMed ID: 18350576
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.
Boer K; Jansen F; Nellist M; Redeker S; van den Ouweland AM; Spliet WG; van Nieuwenhuizen O; Troost D; Crino PB; Aronica E
Epilepsy Res; 2008 Jan; 78(1):7-21. PubMed ID: 18023148
[TBL] [Abstract][Full Text] [Related]
32. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
Zou J; Zhang B; Gutmann DH; Wong M
Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
[TBL] [Abstract][Full Text] [Related]
33. Progressive multifocal cystlike cortical tubers in tuberous sclerosis complex: Clinical and neuropathologic findings.
Chu-Shore CJ; Frosch MP; Grant PE; Thiele EA
Epilepsia; 2009 Dec; 50(12):2648-51. PubMed ID: 19624715
[TBL] [Abstract][Full Text] [Related]
34. Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer.
Ma L; Teruya-Feldstein J; Bonner P; Bernardi R; Franz DN; Witte D; Cordon-Cardo C; Pandolfi PP
Cancer Res; 2007 Aug; 67(15):7106-12. PubMed ID: 17671177
[TBL] [Abstract][Full Text] [Related]
35. Combination of a rapamycin analog (CCI-779) and interferon-gamma is more effective than single agents in treating a mouse model of tuberous sclerosis complex.
Lee L; Sudentas P; Dabora SL
Genes Chromosomes Cancer; 2006 Oct; 45(10):933-44. PubMed ID: 16845661
[TBL] [Abstract][Full Text] [Related]
36. Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome.
Pacey LK; Doering LC
Glia; 2007 Nov; 55(15):1601-9. PubMed ID: 17823967
[TBL] [Abstract][Full Text] [Related]
37. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
[TBL] [Abstract][Full Text] [Related]
38. Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and perituberal cortex.
Ruppe V; Dilsiz P; Reiss CS; Carlson C; Devinsky O; Zagzag D; Weiner HL; Talos DM
Epilepsia; 2014 Apr; 55(4):539-50. PubMed ID: 24512506
[TBL] [Abstract][Full Text] [Related]
39. Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex.
Marcotte L; Aronica E; Baybis M; Crino PB
Acta Neuropathol; 2012 May; 123(5):685-93. PubMed ID: 22327361
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in neurobiology of Tuberous Sclerosis Complex.
Napolioni V; Moavero R; Curatolo P
Brain Dev; 2009 Feb; 31(2):104-13. PubMed ID: 19028034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]